Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections

Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections

US Patent 9987300 · Granted Jun 5, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Long term treatment of HIV-infection with TMC2782024
Degradable removable implant for the sustained release of an active compound2022
Aqueous suspensions of TMC2782022
Long term treatment of HIV-infection with TMC2782021
Prevention of HIV-infection2020
Degradable removable implant for the sustained release of an active compound2020
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2019
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2019
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2019
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2017
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2017
Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of u2017